Home/Filings/4/0001093557-21-000011
4//SEC Filing

DOUBLEDAY RICHARD 4

Accession 0001093557-21-000011

CIK 0001093557other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 8:21 PM ET

Size

14.0 KB

Accession

0001093557-21-000011

Insider Transaction Report

Form 4
Period: 2021-01-22
Transactions
  • Sale

    Common Stock

    2021-01-22$370.24/sh310$114,7768,884 total(indirect: By Trust)
  • Sale

    Common Stock

    2021-01-22$371.98/sh11$4,0928,873 total(indirect: By Trust)
  • Sale

    Common Stock

    2021-01-22$367.51/sh366$134,5109,617 total(indirect: By Trust)
  • Sale

    Common Stock

    2021-01-22$368.20/sh169$62,2269,448 total(indirect: By Trust)
  • Sale

    Common Stock

    2021-01-22$369.31/sh254$93,8049,194 total(indirect: By Trust)
Holdings
  • Common Stock

    21,524
Footnotes (7)
  • [F1]On June 15, 2020, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $366.87 to $367.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F3]Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
  • [F4]This transaction was executed in multiple trades at prices ranging from $367.90 to $368.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $369.16 to $369.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $370.240 to $370.595. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $371.675 to $372.015. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001466545

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:21 PM ET
Size
14.0 KB